RSPO3 and obesity due to melanocortin 4 receptor deficiency: RSPO3's involvement in modulating adipose tissue dynamics via the WNT signaling pathway may contribute to gene-environment interplay, potentially affecting body fat distribution patterns and susceptibility to metabolic diseases like obesity.